A Real-World Evaluation of Risk Factors for Disease Progression in Patients With Polycythemia Vera (PV): An Analysis From the Prospective Observational Study of Patients With Polycythemia Vera in US Clinical Practices (REVEAL)

被引：0
|
作者：
Grunwald, Michael R. [1 ]
Zwicker, Jeffrey I. [2 ,3 ]
Gerds, Aaron T. [4 ]
Burke, John M. [5 ]
Xue, Zhenyi [6 ]
Crowgey, Erin L. [6 ]
Carl, Justine [6 ]
Feldman, Patricia [6 ]
Braunstein, Evan M. [6 ]
Oh, Stephen T. [7 ]
机构：
[1] Atrium Hlth, Levine Canc Inst, Dept Hematol Oncol & Blood Disorders, Charlotte, NC USA
[2] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[3] Weill Cornell Med Coll, Dept Med, New York, NY USA
[4] Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44106 USA
[5] Rocky Mt Canc Ctr, Aurora, CO USA
[6] Incyte Corp, Wilmington, DE USA
[7] Washington Univ, Sch Med, St Louis, MO USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2024年 / 24卷
关键词：
MPN; polycythemia vera; progression; risk factors;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MPN-120
引用
收藏
页码：S415 / S416
页数：2
相关论文
共 50 条
  • [41] Low-risk polycythemia vera treated with phlebotomies: clinical characteristics, hematologic control and complications in 453 patients from the Spanish Registry of Polycythemia Vera
    Ana Triguero
    Alexandra Pedraza
    Manuel Pérez-Encinas
    María Isabel Mata-Vázquez
    Patricia Vélez
    Laura Fox
    Montse Gómez-Calafat
    Regina García-Delgado
    Mercedes Gasior
    Francisca Ferrer-Marín
    Valentín García-Gutiérrez
    Anna Angona
    María Teresa Gómez-Casares
    Beatriz Cuevas
    Clara Martínez
    Raúl Pérez
    José María Raya
    Lucía Guerrero
    Ilda Murillo
    Beatriz Bellosillo
    Juan Carlos Hernández-Boluda
    Cristina Sanz
    Alberto Álvarez-Larrán
    Annals of Hematology, 2022, 101 : 2231 - 2239
  • [42] Real-world, retrospective study evaluating thromboembolic events, associated risk factors, and health-care resource utilization in Japanese patients with polycythemia vera
    Komatsu, Norio
    Jun, GyungJin
    Yonezu, Toshio
    Ohashi, Yasuo
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2020, 112 (02) : 176 - 184
  • [43] Real-world, retrospective study evaluating thromboembolic events, associated risk factors, and health-care resource utilization in Japanese patients with polycythemia vera
    Norio Komatsu
    GyungJin Jun
    Toshio Yonezu
    Yasuo Ohashi
    International Journal of Hematology, 2020, 112 : 176 - 184
  • [44] Patient-Reported Outcomes Data From REVEAL at the Time of Enrollment (Baseline): A Prospective Observational Study of Patients With Polycythemia Vera in the United States
    Mesa, Ruben
    Boccia, Ralph, V
    Grunwald, Michael R.
    Oh, Stephen T.
    Colucci, Philomena
    Paranagama, Dilan
    Parasuraman, Shreekant
    Stein, Brady L.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 (09): : 590 - 596
  • [45] In Contemporary Patients with Polycythemia Vera, Rates of Thrombosis and Risk Factors Delineate a New Clinical Epidemiology
    Barbui, Tiziano
    Carobbio, Alessandra
    Rumi, Elisa
    Finazzi, Guido
    Gisslinger, Heinz
    Rodeghiero, Francesco
    Randi, Maria Luigia
    Rambaldi, Alessandro
    Gisslinger, Bettina
    Pieri, Lisa
    Bertozzi, Irene
    Casetti, Ilaria Carola
    Muellauer, Leonhard
    Pardanani, Animesh
    Thiele, Juergen
    Passamonti, Francesco
    Vannucchi, Alessandro M.
    Tefferi, Ayalew
    BLOOD, 2014, 124 (21)
  • [46] In contemporary patients with polycythemia vera, rates of thrombosis and risk factors delineate a new clinical epidemiology
    Barbui, Tiziano
    Carobbio, Alessandra
    Rumi, Elisa
    Finazzi, Guido
    Gisslinger, Heinz
    Rodeghiero, Francesco
    Randi, Maria Luigia
    Rambaldi, Alessandro
    Gisslinger, Bettina
    Pieri, Lisa
    Bertozzi, Irene
    Casetti, Ilaria
    Pardanani, Animesh
    Passamonti, Francesco
    Vannucchi, Alessandro M.
    Tefferi, Ayalew
    BLOOD, 2014, 124 (19) : 3021 - 3023
  • [47] Characteristics and Clinical Outcomes in Patients (Pts) With Polycythemia Vera (PV) Receiving Ruxolitinib (RUX) After Hydroxyurea HU): A Longitudinal Analysis From REVEAL
    Gerds, Aaron T.
    Grunwald, Michael R.
    Oh, Stephen T.
    Braunstein, Evan
    Xue, Zhenyi
    Bhatt, Valkal
    Yu, Jingbo
    Mesa, Ruben
    BLOOD, 2022, 140 : 6810 - 6812
  • [48] Burden of Phlebotomy in Patients with Polycythemia Vera in the United States: Baseline Data from the REVEAL Study
    Boccia, Ralph V.
    Stein, Brady
    Mesa, Ruben A.
    Naim, Ahmad B.
    Cordaro, Joseph A.
    Peng, Wei
    Sun, Hao
    Parasurama, Shreekant V.
    Moliterno, Alison
    BLOOD, 2015, 126 (23)
  • [49] Incidence of solid tumors or lymphoma in patients with polycythemia vera: Data from the REVEAL study.
    Al-Janadi, Anas
    Patel, Kamal
    Gabrail, Nashat Y.
    Cartwright, Thomas H.
    Zaydan, Muhammad-Ali A.
    Garcia, David A.
    Colucci, Philomena
    Parasuraman, Shreekant
    Paranagama, Dilan
    Stein, Brady
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [50] Risk of second primary malignancy (SPM) and survival of adult patients with polycythemia vera (PV): A US population-based study
    Khanal, Nabin
    Giri, Smith
    Upadhyay, Smrity
    Bhatt, Vijaya Raj
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
12345